全文获取类型
收费全文 | 20611篇 |
免费 | 1282篇 |
国内免费 | 58篇 |
专业分类
耳鼻咽喉 | 333篇 |
儿科学 | 1116篇 |
妇产科学 | 498篇 |
基础医学 | 1807篇 |
口腔科学 | 358篇 |
临床医学 | 1622篇 |
内科学 | 4908篇 |
皮肤病学 | 332篇 |
神经病学 | 1057篇 |
特种医学 | 721篇 |
外科学 | 3705篇 |
综合类 | 479篇 |
一般理论 | 3篇 |
预防医学 | 1100篇 |
眼科学 | 890篇 |
药学 | 1592篇 |
1篇 | |
中国医学 | 73篇 |
肿瘤学 | 1356篇 |
出版年
2023年 | 147篇 |
2022年 | 276篇 |
2021年 | 767篇 |
2020年 | 406篇 |
2019年 | 610篇 |
2018年 | 710篇 |
2017年 | 498篇 |
2016年 | 507篇 |
2015年 | 518篇 |
2014年 | 801篇 |
2013年 | 1006篇 |
2012年 | 1523篇 |
2011年 | 1367篇 |
2010年 | 870篇 |
2009年 | 677篇 |
2008年 | 1015篇 |
2007年 | 1037篇 |
2006年 | 953篇 |
2005年 | 897篇 |
2004年 | 796篇 |
2003年 | 681篇 |
2002年 | 603篇 |
2001年 | 480篇 |
2000年 | 511篇 |
1999年 | 409篇 |
1998年 | 163篇 |
1997年 | 140篇 |
1996年 | 119篇 |
1995年 | 116篇 |
1994年 | 104篇 |
1993年 | 82篇 |
1992年 | 280篇 |
1991年 | 250篇 |
1990年 | 219篇 |
1989年 | 211篇 |
1988年 | 172篇 |
1987年 | 176篇 |
1986年 | 156篇 |
1985年 | 169篇 |
1984年 | 147篇 |
1983年 | 141篇 |
1982年 | 65篇 |
1981年 | 75篇 |
1979年 | 116篇 |
1978年 | 86篇 |
1977年 | 63篇 |
1974年 | 75篇 |
1973年 | 110篇 |
1972年 | 100篇 |
1971年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Context Withania somnifera (L.) Dunal is traditionally used for treating various ailments, but lacks scientific evaluation.Objective This study evaluates Withania somnifera (WS) for its effect on platelet activity and inflammatory enzymes.Materials and methods Aqueous and ethanolic (1:1) leaf extracts were subjected to in vitro indirect haemolytic activity using Naja naja venom, human platelet aggregation was quantified for lipid peroxidation using arachidonic acid (AA) as agonist and 5-lipoxygenase (5-LOX) levels were determined using standard spectrometric assays. Further, molecular docking was performed by the ligand fit method using molegro software package (Molegro ApS, Aarhus, Denmark).Results The study found that aqueous and ethanol extracts have very negligible effect (15%) with an IC50 value of 13.8?mg/mL on PLA2 from Naja naja venom. Further, extracts of WS also had very little effect (18%) with an IC50 value of 16.6?mg/mL on malondialdehyde (MDA) formation. However, a 65% inhibition of 5-LOX with an IC50 value of 0.92?mg/mL was observed in 1:1 ethanol extracts. The same was evident from SAR model with the active ingredient withaferin A binding predominantly on Phe 77, Tyr 98, Arg 99, Asp 164, Leu 168, Ser 382, Arg 395, Tyr 396 and Tyr 614 with an atomic contact energy value of??128.96 compared to standard phenidone (?103.61). Thus, the current study validates the application of WS for inflammatory diseases.Conclusion This study reveals the inhibitory potential of W. somnifera on inflammatory enzymes and platelet aggregation. Thus, WS can serve as a newer, safer and affordable medicine for inflammatory diseases. 相似文献
4.
Rohi Shah Nomaan Sheikh Jitendra Mangwani Nicolette Morgan Hamidreza Khairandish 《Journal of Clinical Orthopaedics and Trauma》2021,12(1):138
Demographic projections for hip fragility fractures indicate a rising annual incidence by virtue of a multimorbid, ageing population with more noncommunicable diseases (NCDs). NCDs are characterised by slow progression and long duration ranging from ischaemic cardiovascular disease, cerebrovascular disease, diabetes, chronic obstructive pulmonary disease to various cancers. Management of this disease burden often involves commencing patients on oral anticoagulants to reduce the risk of thromboembolic events. The use of direct oral anticoagulants (DOACs) in clinical practice has increased due to their rapid onset of action, short half-life and predictable anticoagulant effects, without the need for routine monitoring. Safe and timely surgical intervention relies on reversal of anticoagulants. However, the lack of specific evidence-based guidelines for the perioperative management of patients on DOACs with hip fractures has proved challenging; in particular, the accessibility of DOAC-specific assays, justification of the cost-benefit ratio of targeted reversal agents and indications for neuraxial anaesthesia. This has led to potentially avoidable delays in surgical intervention. Following a literature review of the pharmacokinetic and pharmacodynamics of commonly used DOACs in our region including the role of surrogate markers, we propose a systematic, evidence-based guideline to the perioperative management of hip fractures DOACs. We believe this standardised protocol can be easily replicated between hospitals. We recommend that if patients are deemed suitable for a general anaesthesia, with satisfactory renal function, optimal surgical time should be 24 h following the last ingested dose of DOAC. 相似文献
5.
6.
7.
Bryan Mclaughlin JungHwan Yang Woohyun Yoo Bret Shaw Soo Yun Kim Dhavan Shah 《Health communication》2016,31(6):762-771
The growth of online support groups has led to an expression effects paradigm within the health communication literature. Although religious support expression is characterized as a typical subdimension of emotional support, we argue that in the context of a life-threatening illness, the inclusion of a religious component creates a unique communication process. Using data from an online group for women with breast cancer, we test a theoretical expression effects model. Results demonstrate that for breast cancer patients, religious support expression has distinct effects from general emotional support messages, which highlights the need to further theorize expression effects along these lines. 相似文献
8.
9.
10.